Experience

Davis Polk advised the underwriter in connection with the $138.2 million secondary offering of 10,240,000 common shares of IRSA Propiedades Comerciales S.A. in the form of 2,560,000…

Davis Polk advised Banco Santander, S.A. in connection with its SEC-registered offering of $1 billion aggregate principal amount of 3.125% senior non-preferred fixed-rate notes due 2023, $1…

Davis Polk advised Auris Medical Holding AG in connection with the SEC-registered offering of $1.5 million of its common shares to Lincoln Park Capital Fund, LLC. The common shares are…

Davis Polk is advising Ruby Tuesday, Inc. on its approximately $335 million acquisition by NRD Capital. The transaction, which is expected to be completed during the first quarter of 2018,…

Davis Polk advised the underwriters on a $493.4 million SEC-registered secondary offering of 22,425,000 shares of Class A ordinary shares of Tronox Limited by Exxaro Resources Limited…

Davis Polk advised the joint bookrunners in connection with the international public offering by Grupo Supervielle S.A. and one of its shareholders of 20,155,453 American Depositary…

Davis Polk advised the book-running manager on an SEC-registered offering by Mohawk Capital Finance S.A. of floating-rate notes due 2019. The notes are fully and unconditionally…

Davis Polk advised Banco Santander, S.A. in connection with its underwritten rights offering of 1,458,232,745 ordinary shares. The offering raised gross proceeds of approximately €7.07…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…

Davis Polk advised Ruby Tuesday, Inc., as borrower, in connection with a senior secured 364-day revolving credit facility in the amount of $20 million, including a $15 million letter of…